Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000154683 | SCV000167162 | benign | not specified | 2014-04-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000154683 | SCV000204361 | likely benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | Met9Val in exon 1 of BAG3: This variant is not expected to have clinical signifi cance because it has been identified in 0.3% (13/3734) of African American chrom osomes from a broad population by the NHLBI Exome Sequencing Project (http://evs .gs.washington.edu/EVS; dbSNP rs137965903). |
Invitae | RCV000226527 | SCV000288304 | benign | Myofibrillar myopathy 6; Dilated cardiomyopathy 1HH | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000154683 | SCV000310054 | benign | not specified | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV001705902 | SCV000602619 | benign | not provided | 2023-01-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620469 | SCV000736532 | benign | Cardiovascular phenotype | 2016-01-21 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000154683 | SCV002041664 | likely benign | not specified | 2021-11-29 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000154683 | SCV001920324 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001705902 | SCV001931643 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001705902 | SCV001954211 | likely benign | not provided | no assertion criteria provided | clinical testing |